Zhejiang Ausun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Accelerating Development of APIs & Chemical Intermediates through innovation.
One of their notable products is TASIMELTEON, with a corresponding US DMF Number 32077.
Remarkably, this DMF maintains an Active status since its submission on November 07, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 18, 2018, and payment made on September 20, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II